Phase 1 clinical trial
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $109,674
Award facts
- Contract value 100% obligated
- $109,674.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$295 | |
| Original award | $109,969 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Duke University on December 15, 2020, under the Therapeutics Against Infectious Diseases Phase 1 IDIQ, with a ceiling value of $109,674.20 to de-obligate and close unexpended fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026, period-of-availability closing.
The order is cost, no fee. Place of performance is Durham, NC. The ultimate completion date was December 14, 2021. No set-aside was used. Duke University's Office of Research Administration Division executed this work as part of its broader portfolio of Phase 1 clinical trial unit support for therapeutics against infectious diseases.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 15, 2020.
How much is contract 75N93021F00001 worth?
The government has obligated $109,674 on 75N93021F00001.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under HHSN272201500006I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award